Nutrivigilance (NV) refers to the monitoring and surveillance of the safety and efficacy of nutrients, dietary supplements, and other food-related supplements. The aims of NV are to enhance consumer care and consumer safety in relation to the use of nutraceuticals and to support public health programmes by providing reliable, balanced information for the effective assessment of the risk-benefit profile of supplements. In summary, pharmacovigilance is the systematic monitoring and management of the safety of supplements to ensure their safe and effective use.
Department of Pharmacovigilance of Indus Viva Limited performs all Pharmacovigilance related activities of Indus Viva Limited, Bangalore, India. The pharmacovigilance system of Indus Viva was set up in year 2025. A group of pharmacists and pharmacologists are presently working in this department. Department of Pharmacovigilance maintains separate PV QMS (Pharmacovigilance Quality Management System) to carry out all PV functions including processing ICSRs, monitoring local literature, providing PV awareness training to all employees, communicating & reporting to local Regulatory Authority as well as our Business Partners.
All Serious & Non-serious Adverse Event (AE) or Adverse Drug Reaction (ADR) related to the use of Indus Viva Supplements (manufactured and/or distributed) should be reported to the Department of Pharmacovigilance.
An adverse event report should contain the four essential information:
Name/ Initials
Gender, age
Contact number
Pregnancy status
Name
Occupation
Address
Contact number
Date of onset
Symptoms
Outcome
Seriousness
Medical history
Brand name
Dose, frequency
Route
Batch number
Other medications
Any adverse event regarding Indus Viva’s Supplements (manufactured and/or distributed) can be reported to the Department of Nutrivigilance.
IndusViva HealthSciences Private Limited, No 92-1-36,Viva Tower, Nandi Durga Road, Jayamahal Extension, Bangalore (Banglore) Urban, Karnataka – 560046.
All consumers or consumers are advised to contact their doctor for advice on supplements or any health problems/ medical emergencies. Pharmacovigilance enhances safer use of medicine by monitoring the safety and efficacy of supplements and by providing reliable, balanced information for the effective assessment of the risk-benefit profile of supplements.
Any information related to the identities of the consumer and reporter will be kept confidential unless it is subject to disclose due to regulatory obligation.
1005 | 1013 | 1028 |
1030 | 1227 | 1230 |
4716 | 4719 | 4723 |
4828 | 5176 | 5186 |
5192 | 11713 | 15162 |
15175 | 15736 | 15843 |
18259 | 21030 | 21819 |
21867 | 26413 | 26416 |
31209 | 31683 | 38221 |
38587 | 38678 | 39769 |
39818 | 39952 | 40063 |
41747 | 43494 | 43574 |
50044 | 50570 | 51262 |
51262 | 53142 | 54945 |
55558 | 59235 | 59447 |
59752 | 62346 | 65762 |
67434 | 67756 | 71133 |
71471 | 75673 | 77753 |
77982 | 88452 | 91650 |
91650 | 92395 | 92594 |
93791 | 95538 | 95743 |
102483 | 107480 | 113965 |
130622 | 133350 | 136546 |
139347 | 142681 | 146449 |
146885 | 150288 | 151677 |
153538 | 159459 | 165746 |
174899 | 180227 | 184726 |
197319 | 197552 | 200147 |
202931 | 204850 | 209295 |
216865 | 227597 | 250975 |
251013 | 261587 | 267006 |
295126 | 299339 | 299422 |
323855 | 341771 | 369915 |
388492 | 391744 | 392845 |
393393 | 398124 | 402428 |
403012 | 455226 | 501161 |
533930 | 541319 | 543253 |
571545 | 581896 | 583386 |
584051 | 585835 | 643456 |
716176 | 868554 | 947204 |
997990 | 1048395 |